BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mani SKK, Andrisani O. Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine 2019;124:154518. [PMID: 30126685 DOI: 10.1016/j.cyto.2018.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Yan Y, Chen Z, Hu J, Wang K, Tang N, Li X, Zhou Z. Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest. J Clin Transl Hepatol 2021;9:160-8. [PMID: 34007797 DOI: 10.14218/JCTH.2020.00105] [Reference Citation Analysis]
2 Xu B, Tang B, Wei J. Role of STAT1 in the resistance of HBV to IFN-α. Exp Ther Med 2021;21:550. [PMID: 33850522 DOI: 10.3892/etm.2021.9982] [Reference Citation Analysis]
3 Liu H, Hu B, Huang J, Wang Q, Wang F, Pan F, Chen L. Endoplasmic Reticulum Aminopeptidase 1 Is Involved in Anti-viral Immune Response of Hepatitis B Virus by Trimming Hepatitis B Core Antigen to Generate 9-Mers Peptides. Front Microbiol 2022;13:829241. [PMID: 35602060 DOI: 10.3389/fmicb.2022.829241] [Reference Citation Analysis]
4 Zhao HJ, Hu YF, Han QJ, Zhang J. Innate and adaptive immune escape mechanisms of hepatitis B virus. World J Gastroenterol 2022; 28(9): 881-896 [DOI: 10.3748/wjg.v28.i9.881] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Komatsu H, Inui A, Yoshio S, Fujisawa T. Pharmacotherapy options for managing hepatitis B in children. Expert Opin Pharmacother 2021;22:449-67. [PMID: 33090882 DOI: 10.1080/14656566.2020.1841165] [Reference Citation Analysis]
6 El-mesery M, El-mowafy M, Youssef LF, El-mesery A, Abed SY, Elgaml A. Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients. Journal of Interferon & Cytokine Research 2021;41:52-9. [DOI: 10.1089/jir.2020.0118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu F, Lu R, Liu Y, Wang Y, Tian Y, Li Y, Li M, Wang W, Zhang X, Jia X, Dang S. Efficacy and safety of peginterferon alpha monotherapy in Chinese inactive chronic hepatitis B virus carriers. Liver Int 2021;41:2032-45. [PMID: 33896094 DOI: 10.1111/liv.14897] [Reference Citation Analysis]
8 Zheng K, Shen Y, Xia X, Song Y, Zhang A. Genetic polymorphisms in the IFNL4 , MxA , and MxB genes were associated with biochemical index of chronic HBV patients from Yunnan, China. PeerJ 2022;10:e13353. [DOI: 10.7717/peerj.13353] [Reference Citation Analysis]